Epidemiological Characteristics of the Largest Kidney Transplant Program in Mexico: Western National Medical Center, Mexican Institute of Social Security

2016 ◽  
Vol 48 (6) ◽  
pp. 1999-2005 ◽  
Author(s):  
E. Solis-Vargas ◽  
L.A. Evangelista-Carrillo ◽  
A. Puentes-Camacho ◽  
E. Rojas-Campos ◽  
J. Andrade-Sierra ◽  
...  
2019 ◽  
Vol 20 (4) ◽  
Author(s):  
María de Jesús Nambo Lucio

Background. Non-Hodgkin mantle cell lymphoma (MCL), chronic lymphocytic leukemia (CLL), and multiple myeloma (MM) have in common that they are neoplasms which originate in B cells, they present in adult patients, and there is no therapeutic option which achieves a definitive cure. In Mexico, there is scant information on the incidence and characteristics of these neoplasms. Objective. The objective of the study was to identify the demographic, clinical characteristics and the most frequently used treatments of patients with diagnosis of MCL, CLL, or MM who received care at a Mexican hospital. Material and methods. Aretrospective study was conducted, analyzing the clinical records of patients with diagnosis of MCL, CLL, or MM who received care at the Siglo XXI National Medical Center Cancer Hospital Hematology Service. Results. 399 patients were included, 214, (54%) men and 185 (46%) women, with median age 60 years (38 to 88). The distribution was 31 (8%) patients with MCL, 21(5%) with CLL, and 347 (87%) with MM. The most common initial clinical manifestation was weight loss in MCL and CLL, and lumbar pain in MM. The median time for a patient to see a doctor was greater in patients with MM than in MCL and CLL(7.2 vs. 5 and 6 months). The common denominator in the 3 neoplasms was that most of the patients were in an advanced stage of the disease at the time of diagnosis.Conclusion.  Most of demographic characteristics of patients included  were similar to those described in the literature; however, the age of patients with myeloma was lower, the time to diagnosis was greater and stage of disease at diagnosis was higher than expected.Keywords.Mantle lymphoma, lymphocytic leukemia, multiple myeloma.


2017 ◽  
Vol 35 (15_suppl) ◽  
pp. e15687-e15687 ◽  
Author(s):  
Rafael Medrano Guzman

e15687 Background: Data, incidence and/or prevalence about gastroenteropancreatic neuroendocrine tumors remains unknown in Mexico. Also there is no evidence about any Mexican multicenter study reporting information such as clinical presentation, diagnostic approach and treatment. The biggest problem is the lack of clinical and therapeutic management results so physicians can validate the proper patient protocols. Methods: To know the clinical, epidemiological and therapeutic characteristics of NET-GEP patients treated at the 5 biggest Concentration Mexican Medical Institutions.This paper was developed with the support of 5 Public Medical Institutions: Mexican Social Security Institute (IMSS), Institute for Social Security and Services for State Workers (ISSSTE), Secretary of the Mexican Navy, Petroleos Mexicanos (PEMEX), Ministry of Public Health 495 Patients from 6 hospitals where included: Oncology Hospital, CMN XXI Century, Hospital No. 25 25, Monterrey IMSS, National Cancer Institute (INCAN), National Medical Center November 20, Naval General Hospital of High Specialty and Private Institutions. This was a observational and retrospective academic paper . Results: :Of 495 patients, 59.7% (296) were women and 40.32% (200) were men, 26% of them had around 50 years old. Diagnosis symptoms included: abdominal pain 47.27% (234), gastrointestinal bleeding 18.58% (92) no-predominant symptoms 28.88% (143). Around 32.25% (160) had Carcinoid syndrome and 67.74% (336) were nonfunctioning. The predominant location was pancreas 33.27% (165) and stomach 28.02% (139). 36% resulted circumscribed neoplasia (179), features polypoid 26% (129) and infiltrative 15% (73). The size was > 2cm in 49% (242) > 1-2cm: 36% (180) 0.5 to 1 cm 9% (45) < 0.5 cm 6% (29). Grade: GI 64% (316), GII 13% (66), GIII 23% (114). Metastasis positive ganglioanres (6%) (31), negative (94%) (465). Only seven cases extra nodal metastases (liver (3), lung (2), spleen (2)) Conclusions:This is the first multi-center study in Mexico. Which reflects the clinical characteristics of the NET_GET. The results differ in their epidemiology from that reported in other countries. However, the clinical and therapeutic results are very similar.


2019 ◽  
Vol 20 (1) ◽  
pp. 31-37
Author(s):  
Jong Yun Lee ◽  
Im Seok Koh ◽  
So Hee Lee ◽  
Sung Soo Eun

2013 ◽  
Vol 12 (3) ◽  
pp. 145-151

On October 9, 2013, a group of experts met by telephone to discuss PH in the setting of COPD and IPF. The group consisting of guest editor of this issue Jeffrey Edelman, MD, Head, Lung Transplant Program VA Puget Sound Health System, University of Washington; Deborah J. Levine, MD, Director, Pulmonary Hypertension Center, University of Texas Health Science Center at San Antonio; James Klinger, MD, Director, Rhode Island Hospital Pulmonary Hypertension Center; and Robert Schilz, DO, PhD, Director of Pulmonary Vascular Disease and Lung Transplantation, University Hospitals, Case Medical Center; provided perspective and insight into how clinicians can approach these patients most effectively.


2016 ◽  
Vol 48 (2) ◽  
pp. 575-577 ◽  
Author(s):  
J.C.H. Hernández Rivera ◽  
A. Ibarra Villanueva ◽  
R. Espinoza Pérez ◽  
J.D. Cancino López ◽  
I.R. Silva Rueda ◽  
...  

Transfusion ◽  
2018 ◽  
Vol 59 (2) ◽  
pp. 639-647 ◽  
Author(s):  
Saúl González‐Guzmán ◽  
Vladimir Paredes‐Cervantes ◽  
Bagu Tshima Edward ◽  
José A. Crescencio‐Trujillo ◽  
Ángel Guerra‐Marquez ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document